New imaging agent aims to improve lymphoma staging
NCT ID NCT06125028
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This study tested a new imaging agent called [68Ga]Ga-PentixaFor to see if it could find lymphoma tumors better than the standard PET scan. The trial planned to include adults with marginal zone lymphoma who had not yet been treated. However, the study was stopped early after only 8 people enrolled, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU La Timone
Marseille, 13005, France
-
CHU de Bordeaux
Bordeaux, 33600, France
-
CHU de Nantes
Nantes, 44093, France
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
-
Hôpital Cochin
Paris, 75014, France
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
-
L'IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Meldola, 47014, Italy
-
Medizinische Universität Innsbruck
Innsbruck, 6020, Austria
-
Ospedale San Raffaele S.r.l.
Milan, 20132, Italy
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.